Dual Protein Inhibition Reverses Lung Scarring in Preclinical Study
In a groundbreaking development poised to transform the therapeutic landscape for idiopathic pulmonary fibrosis (IPF), researchers at Virginia Tech’s Fralin Biomedical Research Institute have unveiled...















